University of Cambridge > > Department of Biochemistry - Tea Club Seminars > New trends in Immuno-Oncology - towards personalised cancer treatment

New trends in Immuno-Oncology - towards personalised cancer treatment

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact reception.

Markus Zettl, PhD has more than 15 years experience in research and development in the area of Immuno-Oncology bringing multiple drug candidates to the clinic as well as providing preclinical and translational support for Phase 1 to 2 clinical studies. Before joining CureVac as Vice President leading the Oncology Research & Development organisation, he worked at Boehringer Ingelheim and the mid-size Pieris Pharmaceuticals. Furthermore, he held academic positions at the Laboratory of Molecular Biology (LMB) Cambridge and performed his Ph.D at the European Molecular Biology Laboratory (EMBL) Heidelberg and CRUK , London. Throughout his career he published several high impact publications including Cell and Science and is an inventor on multiple patents.

This talk is part of the Department of Biochemistry - Tea Club Seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity